Gabapentin is not currently listed as a controlled substance under the Controlled Substances Act of 1970. 11 Several state boards of pharmacy, as outlined in Supplemental Table 2 and Figure 1, have independently reclassified gabapentin under state pharmacy rules as a Schedule V drug. Other states have required gabapentin use to be monitored Is Gabapentin a Controlled Substance in All 50 States? No, as of 2022, gabapentin is a Schedule V controlled substance in Alabama, Kentucky, Michigan, North Dakota, Tennessee, Virginia, and West Virginia. Schedule-V controlled substance and mandated reporting to PDMP. The State of Kentucky is, and to date, remains, the only state to have reclassified gabapentin as a Schedule-V controlled substance. 21 Effective July 1, 2017, the prescribing of gabapentin is limited to authorized practitioners, defined as practitioners registered with the US DEA. 21 Thus, mid-level practitioners, specifically Gabapentin (Neurontin) is not a narcotic or federally controlled substance by the DEA as of November 2022, but it is classified as a Schedule V controlled substance in certain states. Some states classify it as a Schedule V controlled substance due to concerns about misuse and its involvement in the opioid crisis. Others do not schedule it but require mandatory reporting to state prescription drug monitoring programs (PDMPs) to track prescribing and dispensing. Eight states have made gabapentin a schedule V controlled substance. And 12 other states require stricter reporting on gabapentin prescriptions. If you have a prescription for gabapentin, it’s best to take the lowest dose possible. In this comprehensive guide, we discuss whether or not gabapentin is considered a controlled substance in different states across the U.S., as well as its possible side effects and dangers if misused or abused. Twelve states have not classified gabapentin as a controlled substance, but require gabapentin dispensing must be reported to their PMP (including CT, DC, IN, KS, MA, MN, NE, NJ, OH, OR, UT, and WY). Gabapentin is not currently listed as a controlled substance under the Controlled Substances Act of 1970.11 Several state boards of pharmacy, as outlined in Supplemental Table 2 and Figure 1, have independently reclassified gabapentin under state pharmacy rules as a Schedule V drug. Other states have required gabapentin use to be monitored Gabapentin isn’t a narcotic or federally controlled substance, but it is regulated and recognized as a controlled substance in certain states. Gabapentin is approved by the Food and Drug States are now taking action to track gabapentin use through prescription monitoring programs, and some states have reclassified it as a Schedule V controlled substance. This commentary summarizes gabapentin's abuse potential, identifies state-level actions regarding gabapentin monitoring, and discusses possible clinical implications and ways Although the anticonvulsant is not considered a controlled substance, some state legislation focuses on monitoring the use of or reclassifying it. The FDA approved gabapentin in 1993 as a non-controlled substance and it has remained a non-controlled substance at the federal level. , any new orders for Gabapentin issued by a practitioner WITHOUT a Utah. Controlled Substance license and a DEA registration will not be valid and MAY NOT be administered or dispensed. Prescription orders (including refills) issued for Gabapentin prior to May 1 , 2024, will not be. aected. It is not legal to distribute Gabapentin samples in Utah. single substance pharmaceutical exposures (i.e., the number of human exposure cases that identified only one substance), gabapentin was identified as a single substance in 6,955 cases in 2022. With respect to medical outcomes associated with gabapentin calls to poison control centers in 2022, gabapentin was associated with 6 deaths, 164 However, some states classify gabapentin as a Schedule V substance or a drug of concern and mandate reporting to PMP. Furthermore, other states are considering similar actions due to increasing evidence of associated risks. Media Contact: LARA Communications 517-373-9280 Email: mediainfo@michigan.gov January 9, 2019 – In an effort to continue to combat the opioid epidemic in Michigan, the Dept. of Licensing and Regulatory Affairs (LARA), with the support of the Michigan Board of Pharmacy, has modified its Pharmacy Rules to categorize Gabapentin as a Schedule 5 controlled substance. In the state of Kentucky, prescribers without a DEA license are unable to prescribe gabapentin after it was classified as a Schedule V controlled substance. 38 This licensing requirement is part of the state’s Controlled Substances Act which had the greatest impact on mid-level practitioners who may not have a DEA license. Kentucky To date, seven US states (AL, KY, MI, ND, TN, VA, and WV) have classified gabapentin as a controlled substance. In a petition filed with the DEA and the US Food and Drug Administration (FDA) in February, the nonprofit advocacy group Public Citizen called for making that regulation federal, in an effort to stop increasing abuse and diversion. Gabapentin is classified as a controlled substance in several states due to its potential for misuse and abuse. Gabapentin, originally developed to treat epilepsy, has gained popularity as a medication for neuropathic pain and other conditions.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | |
![]() | ![]() |